Skip to main content

OptimizeRx Corp

OPRX
Exchange
Nasdaq
Industry
Services-Business Services, NEC
SEC CIK
0001448431

No open-market purchases or sales by OptimizeRx Corp insiders were filed in the last 90 days; 112 institutions reported holding it in 13F filings for Q2 2026, worth $64.2M in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding OptimizeRx Corp changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of OPRX: Q2 2023 compared with Q3 2023
MeasureQ2 2023Q3 2023Change
Holders10295−7
Shares12.9M13.1M+190.5K (+1.5%)
Value$184.1M$101.8M−$82.2M (−44.7%)

New holders (15)

Institutions that held OptimizeRx Corp at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to OPRX in Q3 2023
InstitutionSharesValue% of portfolio
Kennedy Capital Management, Inc.555,675$4.32M0.11%
Samjo Capital LLC316,600$2.46M0.97%
Bridgeway Capital Management, LLC84,100$654.3K0.02%
Boothbay Fund Management, LLC53,829$418.8K0.01%
Walleye Capital LLC23,471$182.6K0.00%
Captrust Financial Advisors22,868$177.9K0.00%
Quadrature Capital Ltd20,916$162.3K0.00%
Jump Financial, LLC13,032$101.4K0.00%
AQR Capital Management LLC12,355$96.1K0.00%
Quarry LP7,923$61.6K0.04%
Quantbot Technologies LP6,303$49.0K0.00%
PEAK6 Investments LLC5,925$46.1K0.00%
Qube Research & Technologies Ltd1,146$8.92K0.00%
L2 Asset Management, LLC12,170$3190.00%
Comerica Bank28$2180.00%

Sold out (22)

Institutions that held OptimizeRx Corp at the end of Q2 2023 and filed for Q3 2023 without it.